ODP397 Small-volume, Subcutaneous, 6-month Leuprolide Acetate Effectively Reduces Growth Velocity to Prepubertal Levels in Children with Central Precocious Puberty

por Klein, Karen O, Atkinson, Stuart N, Boldt-Houle, Deborah M
Publicado 2022

Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men wit...

por Renzulli, Joseph F., Tagawa, Scott T., Atkinson, Stuart N., Boldt‐Houle, Deborah M., Moul, Judd W.
Publicado 2020